Meredith LaRose

University of Oklahoma - Stephenson Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

75

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Leveraging Tumor Growth Rates for Early Decision-Making in NSCLC Using a Novel Analytical Method: An Efficacy Comparison of Sugemalimab with Other Immune Checkpoint Inhibitors in Combination with Chemotherapy

Number of pages: 28 Posted: 09 Dec 2024
Sunil Mahesh Bhatt, Meredith LaRose, Mengxi Zhou, Susan E. Bates, Lawrence H. Schwartz and Tito Fojo
Columbia University - Department of Medicine, University of Oklahoma - Stephenson Cancer Center, Columbia University - Department of Medicine, Columbia University - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Radiology and Columbia University - Department of Medicine
Downloads 75 (685,949)

Abstract:

Loading...

non-small cell lung cancer, lung cancer, immunotherapy, immune therapy, sugemalimab, checkpoint inhibitor, cejemly